• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比增强超声检查下肝内胆管癌合并肝细胞癌的影像学特征:与临床病理结果的相关性

Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.

作者信息

Ye J, Xie X, Lin Y, Liu B, Wang W, Huang X, Huang G

机构信息

Department of Medical Ultrasonics, Division of Interventional Ultrasound, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhong Shan Road 2, Guangzhou, 510080, China.

Department of Medical Ultrasonics, Division of Interventional Ultrasound, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhong Shan Road 2, Guangzhou, 510080, China.

出版信息

Clin Radiol. 2018 Mar;73(3):237-243. doi: 10.1016/j.crad.2017.10.003. Epub 2017 Nov 6.

DOI:10.1016/j.crad.2017.10.003
PMID:29122222
Abstract

AIM

To evaluate the relationship between the imaging features of combined hepatocellular-cholangiocarcinoma (CHC) on contrast-enhanced ultrasound (CEUS) and clinicopathological findings.

MATERIALS AND METHODS

From August 2004 to August 2016, 40 patients (29 males, 11 females; mean age 52.8±11.2 years) with histopathologically proven CHC were investigated. The CEUS imaging features and clinicopathological findings of CHC were analysed and compared retrospectively.

RESULTS

On CEUS, peripheral irregular rim-like enhancement, diffuse heterogeneous enhancement, and diffuse homogeneous enhancement was illustrated in 13 (32.5%), 21 (52.5%), and six (15%) lesions, respectively. Histopathological findings showed hepatocellular carcinoma (HCC) predominance and cholangiocarcinoma (CC) predominance throughout the tumour were illustrated in 21 (52.5%) and 19 (47.5%) cases, respectively. HCC-predominant CHCs displayed diffuse heterogeneous enhancement more frequently than peripheral irregular rim-like enhancement (p=0.005), whereas CC-predominant CHCs displayed peripheral irregular rim-like enhancement more frequently than diffuse heterogeneous enhancement and homogeneous enhancement (p=0.005 and p=0.01, respectively). CHCs >5 cm displayed diffuse heterogeneous enhancement more frequently than diffuse homogeneous enhancement, whereas CHCs ≤5 cm displayed diffuse homogeneous enhancement more frequently than diffuse heterogeneous enhancement (p=0.004).

CONCLUSION

The enhancement pattern of CHC on CEUS depended on the relative proportions of the HCC and CC components and showed size-dependent characteristics.

摘要

目的

评估肝细胞-胆管细胞癌(CHC)在超声造影(CEUS)下的影像学特征与临床病理结果之间的关系。

材料与方法

对2004年8月至2016年8月期间40例经组织病理学证实为CHC的患者(男性29例,女性11例;平均年龄52.8±11.2岁)进行研究。回顾性分析并比较CHC的CEUS影像学特征和临床病理结果。

结果

在CEUS上,13个(32.5%)、21个(52.5%)和6个(15%)病灶分别表现为周边不规则环状强化、弥漫性不均匀强化和弥漫性均匀强化。组织病理学结果显示,肿瘤整体以肝细胞癌(HCC)为主和以胆管细胞癌(CC)为主的病例分别为21例(52.5%)和19例(47.5%)。以HCC为主的CHC表现为弥漫性不均匀强化的频率高于周边不规则环状强化(p=0.005),而以CC为主的CHC表现为周边不规则环状强化的频率高于弥漫性不均匀强化和均匀强化(分别为p=0.005和p=0.01)。直径>5 cm的CHC表现为弥漫性不均匀强化的频率高于弥漫性均匀强化,而直径≤5 cm的CHC表现为弥漫性均匀强化的频率高于弥漫性不均匀强化(p=0.004)。

结论

CHC在CEUS上的强化模式取决于HCC和CC成分的相对比例,并呈现出大小依赖性特征。

相似文献

1
Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.对比增强超声检查下肝内胆管癌合并肝细胞癌的影像学特征:与临床病理结果的相关性
Clin Radiol. 2018 Mar;73(3):237-243. doi: 10.1016/j.crad.2017.10.003. Epub 2017 Nov 6.
2
Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.超声造影和肿瘤标志物在鉴别肝内胆管癌与肝细胞癌及胆管癌中的潜在诊断效能
J Med Ultrason (2001). 2018 Apr;45(2):231-241. doi: 10.1007/s10396-017-0834-1. Epub 2017 Oct 20.
3
Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma.乙型肝炎病毒相关的肝细胞-胆管细胞癌的超声造影成像特征及临床特点:与乙型肝炎病毒相关肝细胞癌的比较
Ultrasound Med Biol. 2017 Nov;43(11):2530-2536. doi: 10.1016/j.ultrasmedbio.2017.07.016. Epub 2017 Aug 26.
4
Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.高危患者肝内胆管细胞癌与肝细胞癌的鉴别诊断:应用超声造影的预测模型。
World J Gastroenterol. 2018 Sep 7;24(33):3786-3798. doi: 10.3748/wjg.v24.i33.3786.
5
Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.超声造影在鉴别肝细胞癌和胆管细胞癌中的应用。
Ultraschall Med. 2012 Dec;33(7):E191-E195. doi: 10.1055/s-0031-1282029. Epub 2011 Dec 22.
6
Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.动态对比增强超声(DCE-US)用于肝细胞癌和胆管细胞癌的特征描述。
Ultraschall Med. 2014 Dec;35(6):522-7. doi: 10.1055/s-0034-1385170. Epub 2014 Sep 9.
7
Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.动态对比增强超声在非肝硬化肝脏肝细胞癌和肝内胆管细胞癌鉴别诊断中的应用。
Ultrasound Med Biol. 2023 Aug;49(8):1780-1788. doi: 10.1016/j.ultrasmedbio.2023.03.026. Epub 2023 May 6.
8
Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature.超声造影在混合型肝细胞肝癌中的应用:病例系列与文献复习。
Dig Liver Dis. 2018 Apr;50(4):401-407. doi: 10.1016/j.dld.2017.11.003. Epub 2017 Nov 24.
9
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
10
Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.超声造影在鉴别小(≤3厘米)肝细胞癌与肝内胆管癌中的特征
Medicine (Baltimore). 2018 Oct;97(41):e12781. doi: 10.1097/MD.0000000000012781.

引用本文的文献

1
The correlation between contrast-enhanced ultrasound Liver Imaging Reporting and Data System classification and differentiation grades of combined hepatocellular carcinoma-cholangiocarcinoma.超声造影肝脏影像报告和数据系统分类与肝细胞癌-胆管癌合并症分化程度之间的相关性
Quant Imaging Med Surg. 2025 Jan 2;15(1):259-271. doi: 10.21037/qims-24-1483. Epub 2024 Dec 23.
2
Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics.使用CEUS LI-RADS对肝内胆管癌-肝细胞癌混合型进行评估:与病理特征的相关性
Abdom Radiol (NY). 2025 Feb;50(2):646-655. doi: 10.1007/s00261-024-04519-x. Epub 2024 Aug 16.
3
Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma.
联合肝细胞癌和胆管癌诊断中的非侵入性成像
Abdom Radiol (NY). 2023 Jun;48(6):2019-2037. doi: 10.1007/s00261-023-03879-0. Epub 2023 Mar 24.
4
CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma.对比增强超声和CT/MRI肝脏影像报告和数据系统联合血清生物标志物用于鉴别肝细胞癌合并胆管癌与肝细胞癌
Front Oncol. 2022 May 16;12:897090. doi: 10.3389/fonc.2022.897090. eCollection 2022.
5
Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators.基于超声特征和临床指标的列线图在术前鉴别肝细胞胆管癌与肝细胞癌及肝内胆管癌中的应用
Front Oncol. 2022 Feb 15;12:757774. doi: 10.3389/fonc.2022.757774. eCollection 2022.
6
Evaluation of Cardiac Space-Occupying Lesions by Myocardial Contrast Echocardiography and Transesophageal Echocardiography.心肌声学造影与经食管超声心动图评价心脏占位性病变。
J Healthc Eng. 2022 Jan 25;2022:2066033. doi: 10.1155/2022/2066033. eCollection 2022.
7
Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver.2017版CEUS LI-RADS在鉴别甲胎蛋白阴性肝细胞癌与肝脏其他原发性恶性肿瘤中的诊断价值
Diagnostics (Basel). 2021 Dec 1;11(12):2250. doi: 10.3390/diagnostics11122250.
8
Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.肝细胞癌-胆管细胞癌混合癌的临床病理特征及复发模式。
World J Surg Oncol. 2020 Dec 4;18(1):319. doi: 10.1186/s12957-020-02099-w.
9
Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma.肝细胞胆管癌的超声造影成像特征及临床特点:与肝细胞癌和胆管癌的比较
Ultrasonography. 2020 Oct;39(4):356-366. doi: 10.14366/usg.19093. Epub 2020 Mar 13.
10
Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound.通过miRNA与超声联合鉴定肝内胆管结石相关胆管癌
Cancer Manag Res. 2020 Mar 12;12:1845-1853. doi: 10.2147/CMAR.S241870. eCollection 2020.